Sasagu Kurozumi
9PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Aug 24, 2024
Research on biomarkers using innovative artificial intelligence systems in breast cancer.Sasagu Kurozumi, Graham R Ball
|Nov 15, 2019
Clinicopathological values of PD-L1 expression in HER2-positive breast cancer.Sasagu Kurozumi, Kenichi Inoue, Hiroshi Matsumoto
|Nov 11, 2019
Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer.Sasagu Kurozumi, Sami Alsaeed, Nnamdi Orah
|Jul 11, 2019
β2-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer.Sasagu Kurozumi, Kyoichi Kaira, Hiroshi Matsumoto
|May 22, 2019
Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy.Sasagu Kurozumi, Yuri Yamaguchi, Hiroshi Matsumoto
|Apr 04, 2019
Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.Sasagu Kurozumi, Chitra Joseph, Sara Raafat
Pageof 2
